Reported Feb 24, 2021 · Terminated

Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories,…

Ascend Laboratories LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Ascend Laboratories LLC · 339 Jefferson Rd Ste 101 · Parsippany, NJ · 07054-3707

Is this the product you have?

  • Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only
  • Manufactured byAlkem Laboratories, Ltd
  • Mumbai -400 013 INDIA Distributed byAscend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68
Lot codes and dates
    • Lot #: 19141869
    • 19141870
    • EXP 3/2021
    • 19142762
    • EXP 5/2021
    • 19143826
    • 19143923
    • 19143941
    • 19143954 EXP 7/2021
Amount recalled
23,436 200 mL bottles

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Ascend Laboratories LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Dec 2, 2022 · Data as of Sep 19, 6:37 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.